August 13, 2019 — Global 3D cell culture market report published by Accurize Market Research forecast that the global market is expected to reach $5 billion by 2025; growing at a CAGR of 23.4% from 2017 to 2025. By geography, Asia Pacific and North America are expected to grow at a CAGR of 25% and 23%, respectively, during the forecast period.
Rising investment on R&D by various pharmaceutical and biotechnological companies across the globe to drive the growth of the market
Growing need for organ transplantation due to large patient database and ban on research and testing on animals fuel the demand for the global 3D cell culture market. Moreover, rising investment on R&D by various pharmaceutical and biotechnological companies also boosts the growth of the market.
The global 3D cell culture market has been bifurcated on the basis of technology, application, end-user, and geography. Technology segment is categorized as extracellular matrices, bioreactors, gels, Scaffold free platform, and microchips. Further, applications segment includes research, drug discovery, tissue engineering, clinical applications, and stem cell biology. End-user is further categorized into biotechnology & biopharmaceutical industry, research laboratories & institutes, and hospital & diagnostic centers.
By geography the market is segmented into North America, Europe, Asia-Pacific and Rest of the World (RoW). The U.S., Canada, and Mexico are covered under North America wherein Europe covers UK, Germany, France Italy, and others. Asia-Pacific covers China, Japan, India, South Korea, and others. RoW covers South America, Middle East, and Africa.
“Extracellular matrices accounted for the largest market share in the technology segment", says Accurize
By technology, extracellular matrices segment accounted for the largest market share in 2017, and is expected to grow with fastest CAGR in the component segment during the forecast period 2017 – 2025. Moreover, research and drug discovery dominated the application segment with largest market share in 2017.
“Biotechnology & biopharmaceutical industry accounted for the largest market share in the end-user segment", says Accurize
By end-user segment, biotechnology & biopharmaceutical industry accounted for the largest market share in 2017 and in terms of growth, research laboratories & institutes is likely to grow with fastest CAGR during the forecast period.
“Europe dominated the global market with the highest market share over the forecast period", says Accurize
In 2017, Europe accounted the largest share of the market followed by North America. Moreover, Asia Pacific is the fastest growing region in the global 3D cell culture market, owning to increasing government funding for research and development and rising scope for outsourcing.
Ask for customization:
Top players in the market
The key market players include Merck & Co., Inc., 3D Biotek LLC, Lonza Group, Kuraray Co., Ltd., Corning Incorporated, Becton, Advanced Biomatrix, Inc., Thermo Fisher Scientific Inc., Dickinson and Company, VWR International, LLC, and Global Cell Solutions, Inc., among others.
-- end ---